Active

OCTIMET Oncology

Switched

BE0651853757

Rechtspersoon Public limited company 1 establishment

Oudepostelseweg 1, 2440 Geel Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

10 year, 4 months

Financials

Financial year 2025

Gross margin

€ -16,540

▲ 71% vs 2024

Profit

Caution

€ -95,727

▼ 153% vs 2024

Debts

Low

€ 9,125

▲ 68% vs 2024

OCTIMET Oncology from Geel, company number BE0651853757, closed financial year 2025 with a result of € -95,727 after tax. For that financial year OCTIMET Oncology recorded a gross margin of € -16,540 and equity of € 243,628. Compared with financial year 2024, the result moved from € 179,816 to € -95,727. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What happened at OCTIMET Oncology?

What happened at OCTIMET Oncology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Iker Huerga stepped down as director. NBB
  • Timothy Perera stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 95,727 (▼ 153% vs 2024). Source: NBB ↗
  • Iker Huerga became a director. NBB
  • Timothy Perera became a director. NBB
  • New establishment in Gent. KBO
  • Start of the company according to the CBE. KBO

In short

From € 152,305 loss in 2021 to € 95,727 loss in 2025.

Paid € 42,417 in corporate taxes since 2021.

Best year ever: 2024, with € 179,816 profit.

A new publication or filing at OCTIMET Oncology? We notify you, reason included.

Follow OCTIMET Oncology

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

Timothy Perera

Director

since 2024 · until 2030

Iker Huerga

Director

since 2026 · until 2032

Establishments

Establishment units

Physical locations of this company

Registered office

Oudepostelseweg 1

2440 Geel

2.253.361.270

Pieter van Reysschootlaan 2 box 104

9051 Gent

Active since 12 April 2016

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0651.853.757
VAT number
BE 0651.853.757
Registered office
Oudepostelseweg 1, 2440 Geel
Names & denominations
OCTIMET Oncology
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
12 April 2016
Peppol
Active · Active since 10 Mar 2026
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What is the enterprise number of OCTIMET Oncology?
The enterprise number of OCTIMET Oncology is BE0651853757.
What is the address of OCTIMET Oncology?
The registered office of OCTIMET Oncology is located at Oudepostelseweg 1, 2440 Geel.
When was OCTIMET Oncology founded?
OCTIMET Oncology was founded on 12 April 2016.
What is the main activity of OCTIMET Oncology?
The main activity of OCTIMET Oncology is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does OCTIMET Oncology have a website?
No website is currently known for OCTIMET Oncology.
How much profit did OCTIMET Oncology make in 2025?
OCTIMET Oncology recorded a loss after taxes of € 95,727 in financial year 2025.
What is the revenue of OCTIMET Oncology?
As a small company, OCTIMET Oncology is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -16,540.
Where can I find the annual accounts of OCTIMET Oncology?
OCTIMET Oncology files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of OCTIMET Oncology?
According to the 2025 annual accounts, the directors of OCTIMET Oncology are: Timothy Perera, Iker Huerga.